S-Adenosylhomocysteine

S-Adenosylhomocysteine

SCHEMBL21160481

Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC[C@H](N)C(=O)O)[C@H](O)[C@@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DOT1L Q8TEK3 9/20 1.00
DNMT1 P26358 7/20 1.00
DNMT3B Q9UBC3 6/20 1.00
EZH2 Q15910 4/20 1.00
CARM1 Q86X55 2/20 1.00
EHMT2 Q96KQ7 2/20 1.00
PRMT1 Q99873 2/20 1.00
NNMT P40261 2/20 1.00
TRDMT1 O14717 1/20 1.00
PRMT5 O14744 1/20 1.00
SUV39H1 O43463 1/20 1.00
PRMT3 O60678 1/20 1.00
INMT O95050 1/20 1.00
NSD2 O96028 1/20 1.00
PNMT P11086 1/20 1.00
HNMT P50135 1/20 1.00
WDR5 P61964 1/20 1.00
KMT2A Q03164 1/20 1.00
SETDB1 Q15047 1/20 1.00
RBBP5 Q15291 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
S-Adenosylhomocysteine SCHEMBL804238 1.00 DOT1L (1.00) DOT1LDNMT1DNMT3BEZH2CARM1
S-Adenosylhomocysteine SCHEMBL13033864 1.00 DOT1L (1.00) DOT1LDNMT1DNMT3BEZH2CARM1
S-Adenosylhomocysteine SCHEMBL10871157 1.00 DOT1L (1.00) DOT1LDNMT1DNMT3BEZH2CARM1
S-Adenosylhomocysteine SCHEMBL17087726 1.00 DOT1L (1.00) DOT1LDNMT1DNMT3BEZH2CARM1
S-Adenosylhomocysteine SCHEMBL14434697 1.00 DOT1L (1.00) DOT1LDNMT1DNMT3BEZH2CARM1
S-Adenosylhomocysteine SCHEMBL18826562 1.00 DOT1L (1.00) DOT1LDNMT1DNMT3BEZH2CARM1
S-Adenosylhomocysteine SCHEMBL17316165 1.00 DOT1L (1.00) DOT1LDNMT1DNMT3BEZH2CARM1
S-Adenosylhomocysteine SCHEMBL13073142 1.00 DOT1L (1.00) DOT1LDNMT1DNMT3BEZH2CARM1
S-Adenosylhomocysteine SCHEMBL12378912 1.00 DOT1L (1.00) DOT1LDNMT1DNMT3BEZH2CARM1
S-Adenosylhomocysteine SCHEMBL14411397 1.00 DOT1L (1.00) DOT1LDNMT1DNMT3BEZH2CARM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3885343-A1 INDOLE COMPOUNDS AS EZH2 INHIBITORS AND USES THEREOF Dana-Farber Cancer Institute, Inc. (US) 2021-09-29 EP disclosed
US-10337049-B2 Universal methylation profiling methods THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2019-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10337049-B2 Universal methylation profiling methods DNMT1, DNMT3A, DNMT3B DOT1L 64/4885DNMT1 1/4885DNMT3B 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.